TD-9 Exploring the use of darunavir boosted plus dolutegravir in highly treatment-experienced HIV population: a retrospective Cohort study
Andrea De Vito(University of Sassari), Antonio Di Biagio, Mariachiara Cerchiaro(University of Padua), Marianna Menozzi(Azienda Ospedaliero-Universitaria di Modena), A Cozzi-Lepri, Giulia Maria Stella(Ospedale Misericordia - Grosseto), Adriana Raddi(Ospedale di Belcolle), Paolo Fusco(Magna Graecia University), Gisele Pedroso Moi(University of Sassari), Denis Stanev(Gran Sasso Science Institute), Eeva Tortellini(Policlinico Umberto I), Antonia Bezenchek(Informa (Italy)), Francesco Stefanelli(Ospedale Policlinico San Martino), Salvatore Rotundo(Magna Graecia University), Nunzia Cuomo(Federico II University Hospital), Matteo Guardiani(Policlinico Umberto I), Barbara Rossetti, Giorgia Brucci(Ospedale Policlinico San Martino)
Cited by 0
Related Papers
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846